TTN and cancer: we found that the immune signatures (CD8+ T cells, CD4+ T cell, Macrophage, Neutrophil and Dendritic cell) showed significantly higher enrichment levels in TTN-wildtype than in TTN- mutated cancers in LIHC (P < 0.01) (Fig 7B).